Total Payments
$5,337
2024 Payments
$1,042
Companies
53
Transactions
249
Medicare Patients
2,894
Medicare Billing
$625,237
Payment Breakdown by Category
Food & Beverage$4,954 (92.8%)
Education$382.72 (7.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,954 | 238 | 92.8% |
| Education | $382.72 | 11 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $734.39 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $671.78 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $374.12 | 22 | $0 (2024) |
| Amgen Inc. | $318.49 | 13 | $0 (2023) |
| PFIZER INC. | $246.75 | 15 | $0 (2024) |
| Celgene Corporation | $207.43 | 10 | $0 (2024) |
| Exelixis Inc. | $194.48 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $181.56 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $167.59 | 6 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $133.12 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,042 | 45 | Novartis Pharmaceuticals Corporation ($157.80) |
| 2023 | $1,156 | 48 | Novartis Pharmaceuticals Corporation ($171.33) |
| 2022 | $970.65 | 41 | Janssen Biotech, Inc. ($170.47) |
| 2021 | $302.28 | 15 | Novartis Pharmaceuticals Corporation ($69.57) |
| 2020 | $101.30 | 6 | Janssen Biotech, Inc. ($60.71) |
| 2019 | $444.24 | 23 | PFIZER INC. ($81.96) |
| 2018 | $655.27 | 34 | Exelixis Inc. ($152.36) |
| 2017 | $665.17 | 37 | Amgen Inc. ($180.08) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 4 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/26/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Oncology | ||||||
| 05/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $36.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/28/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug), LUTATHERA | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Oncology | ||||||
| 04/24/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Hematology | ||||||
| 04/08/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 03/31/2023 | Heron Therapeutics, Inc. | CINVANTI (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: CHEMO INDUCED NAUSEA VOMITING | ||||||
| 03/25/2023 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Oncology | ||||||
| 03/10/2023 | GENZYME CORPORATION | SARCLISA (Biological), ELITEK | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Oncology | ||||||
| 03/03/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 02/24/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Oncology | ||||||
| 02/16/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.92 | General |
| Category: Oncology | ||||||
| 02/10/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $26.92 | General |
| Category: ONCOLOGY | ||||||
| 02/04/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Oncology | ||||||
| 01/14/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.98 | General |
| Category: Oncology | ||||||
| 01/06/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Oncology | ||||||
| 12/30/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Oncology | ||||||
| 12/24/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $37.75 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $33.71 | General |
| 12/10/2022 | Lilly USA, LLC | CYRAMZA (Drug), RETEVMO | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Oncology | ||||||
| 12/02/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: Oncology | ||||||
| 11/18/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Oncology | ||||||
| 11/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,071 | 6,487 | $483,411 | $262,921 |
| 2022 | 11 | 854 | 2,512 | $335,940 | $180,444 |
| 2021 | 9 | 639 | 1,699 | $305,353 | $142,210 |
| 2020 | 5 | 330 | 707 | $143,492 | $39,662 |
Total Patients
2,894
Total Services
11,405
Medicare Billing
$625,237
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 554 | $104,501 | $60,551 | 57.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 197 | 1,016 | $67,544 | $43,952 | 65.1% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 22 | 2,600 | $80,817 | $41,958 | 51.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 109 | 559 | $68,187 | $38,454 | 56.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 153 | 162 | $37,825 | $18,364 | 48.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 92 | $31,494 | $13,881 | 44.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 81 | $20,959 | $10,096 | 48.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $18,617 | $9,939 | 53.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 104 | 106 | $18,344 | $7,693 | 41.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 42 | 86 | $11,214 | $5,224 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 64 | $8,364 | $4,890 | 58.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 16 | 145 | $8,091 | $3,891 | 48.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 23 | $5,807 | $3,186 | 54.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 59 | $1,469 | $757.56 | 51.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 15 | 888 | $177.50 | $84.81 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 392 | $73,943 | $44,534 | 60.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 207 | 1,083 | $71,998 | $37,037 | 51.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 143 | 582 | $71,109 | $36,547 | 51.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 138 | 152 | $52,034 | $26,542 | 51.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 139 | 141 | $32,922 | $16,806 | 51.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 33 | $8,332 | $5,393 | 64.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $9,308 | $5,087 | 54.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 42 | $7,396 | $3,766 | 50.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 22 | 22 | $3,807 | $1,958 | 51.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 15 | 21 | $2,738 | $1,396 | 51.0% |
About Dr. Arjun Sood, M.D
Dr. Arjun Sood, M.D is a Hematology & Oncology healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518092766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arjun Sood, M.D has received a total of $5,337 in payments from pharmaceutical and medical device companies, with $1,042 received in 2024. These payments were reported across 249 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($4,954).
As a Medicare-enrolled provider, Sood has provided services to 2,894 Medicare beneficiaries, totaling 11,405 services with total Medicare billing of $625,237. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Alexandria, VA
- Active Since 02/21/2007
- Last Updated 08/20/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1518092766
Products in Payments
- OPDIVO (Biological) $294.15
- IMBRUVICA (Drug) $228.97
- DARZALEX (Biological) $216.68
- MEKINIST (Drug) $198.01
- ERLEADA (Drug) $183.33
- LIBTAYO (Biological) $167.59
- KISQALI (Drug) $141.08
- NINLARO (Drug) $135.03
- KEYTRUDA (Biological) $134.55
- LONSURF (Drug) $126.34
- SCEMBLIX (Drug) $109.42
- XTANDI (Drug) $94.84
- XARELTO (Drug) $86.25
- Cabometyx (Drug) $83.24
- ADCETRIS (Biological) $82.78
- BRUKINSA (Drug) $74.61
- Revlimid (Drug) $74.51
- Enhertu (Drug) $70.67
- IBRANCE (Drug) $65.19
- KRAZATI (Drug) $64.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Alexandria
Vinni Juneja, Md, MD
Hematology & Oncology — Payments: $35,341
Hematology & Oncology $35,341
Dr. Bassam Abi-Rached, M.d, M.D
Hematology & Oncology — Payments: $13,951
Hematology & Oncology $13,951
Dr. Howard Wold, M.d, M.D
Hematology & Oncology — Payments: $9,956
Hematology & Oncology $9,956
Dr. Hafez Halawani, Md, MD
Hematology & Oncology — Payments: $9,228
Hematology & Oncology $9,228
Dr. Anastas Provatas, Md, MD
Hematology & Oncology — Payments: $8,801
Hematology & Oncology $8,801
Dr. Christine Ince, M.d, M.D
Hematology & Oncology — Payments: $6,678
Hematology & Oncology $6,678